Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Histogen stock | $1.24

Own Histogen stock in just a few minutes.

Fact checked

Histogen Inc is a biotechnology business based in the US. Histogen shares (HSTO) are listed on the NASDAQ and all prices are listed in US Dollars. Histogen employs 22 staff and has a trailing 12-month revenue of around USD$3.1 million.

How to buy shares in Histogen

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Histogen. Find the stock by name or ticker symbol: HSTO. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Histogen reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$1.24, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Histogen, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Histogen. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Histogen share price

Use our graph to track the performance of HSTO stocks over time.

Histogen shares at a glance

Information last updated 2020-12-27.
Latest market closeUSD$1.24
52-week rangeUSD$0.2303 - USD$5
50-day moving average USD$1.3858
200-day moving average USD$2.261
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-3.0506

Buy Histogen shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Histogen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Histogen price performance over time

Historical closes compared with the close of $1.24 from 2020-12-09

1 week (2021-01-07) 40.91%
1 month (2020-12-17) 4.20%
3 months (2020-10-15) -38.00%
6 months (2020-07-15) -57.97%
1 year (2020-01-15) 197.50%
2 years (2019-01-15) -31.87%
3 years (2018-01-13) N/A
5 years (2016-01-15) 1.65

Histogen financials

Revenue TTM USD$3.1 million
Gross profit TTM USD$3.1 million
Return on assets TTM -82.09%
Return on equity TTM -338.53%
Profit margin 0%
Book value N/A
Market capitalisation USD$18 million

TTM: trailing 12 months

Shorting Histogen shares

There are currently 74,916 Histogen shares held short by investors – that's known as Histogen's "short interest". This figure is 85.4% up from 40,402 last month.

There are a few different ways that this level of interest in shorting Histogen shares can be evaluated.

Histogen's "short interest ratio" (SIR)

Histogen's "short interest ratio" (SIR) is the quantity of Histogen shares currently shorted divided by the average quantity of Histogen shares traded daily (recently around 576276.92307692). Histogen's SIR currently stands at 0.13. In other words for every 100,000 Histogen shares traded daily on the market, roughly 130 shares are currently held short.

However Histogen's short interest can also be evaluated against the total number of Histogen shares, or, against the total number of tradable Histogen shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Histogen's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Histogen shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Histogen shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Histogen.

Find out more about how you can short Histogen stock.

Histogen share dividends

We're not expecting Histogen to pay a dividend over the next 12 months.

Have Histogen's shares ever split?

Histogen's shares were split on a 1:10 basis on 27 May 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Histogen shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Histogen shares which in turn could have impacted Histogen's share price.

Histogen overview

Histogen Inc., a regenerative medicine company, develops therapies based upon the products of cells grown under simulated embryonic conditions. It offers human multipotent cell conditioned media (CCM); human extracellular matrix (hECM); and hair stimulating complex (HSC). The company's technology focuses on stimulating a patient's own stem cells by delivering a complex of multipotent human proteins that support stem cell growth and differentiation. Histogen Inc. is headquartered San Diego, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site